$WNLV
Winvest Group Ltd

2024 Q2 Form 10-Q Financial Statement

#000147793224005146 Filed on August 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q2
Revenue $12.50K $54.77K
YoY Change -77.18% 1269.23%
Cost Of Revenue $5.840K $39.83K
YoY Change -85.34%
Gross Profit $6.660K $14.94K
YoY Change -55.42% 273.53%
Gross Profit Margin 53.28% 27.28%
Selling, General & Admin $148.0K $139.4K
YoY Change 6.15% 140.6%
% of Gross Profit 2222.37% 933.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $148.0K $139.4K
YoY Change 6.16% 39.37%
Operating Profit -$141.4K -$124.5K
YoY Change 13.55% 29.62%
Interest Expense $833.00 $6.099K
YoY Change -86.34% 3076.56%
% of Operating Profit
Other Income/Expense, Net $87.61K $8.214K
YoY Change 966.64% -13138.1%
Pretax Income -$53.74K -$116.3K
YoY Change -53.78% 20.99%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$53.74K -$116.3K
YoY Change -53.78% 20.99%
Net Earnings / Revenue -429.92% -212.3%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 635.2M shares 17.53M shares
Diluted Shares Outstanding 17.53M shares

Balance Sheet

Concept 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.13K $113.2K
YoY Change -66.32% 309.4%
Cash & Equivalents $38.13K $113.2K
Short-Term Investments
Other Short-Term Assets $117.2K $8.390K
YoY Change 1296.66% 217.8%
Inventory
Prepaid Expenses $117.2K $7.299K
Receivables $19.20K $15.42K
Other Receivables $0.00 $0.00
Total Short-Term Assets $178.0K $150.2K
YoY Change 18.48% 365.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.830K
YoY Change
Other Assets $1.090K
YoY Change
Total Long-Term Assets $10.92K $1.094K
YoY Change 898.17% -99.94%
TOTAL ASSETS
Total Short-Term Assets $178.0K $150.2K
Total Long-Term Assets $10.92K $1.094K
Total Assets $188.9K $151.3K
YoY Change 24.84% -92.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.328K $64.39K
YoY Change -96.38% 227.43%
Accrued Expenses $58.94K $15.70K
YoY Change 275.29% 25.27%
Deferred Revenue
YoY Change
Short-Term Debt $633.9K $770.2K
YoY Change -17.69% 114.38%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $945.2K $950.3K
YoY Change -0.54% 142.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $945.2K $950.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $945.2K $950.3K
YoY Change -0.54% 142.75%
SHAREHOLDERS EQUITY
Retained Earnings -$104.8M -$104.6M
YoY Change 0.16% 2.83%
Common Stock $85.16K $17.53K
YoY Change 385.9% 0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$756.3K -$799.0K
YoY Change
Total Liabilities & Shareholders Equity $188.9K $151.3K
YoY Change 24.84% -92.47%

Cashflow Statement

Concept 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$53.74K -$116.3K
YoY Change -53.78% 20.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$227.0K -$70.80K
YoY Change 220.62% 18.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $87.50K $0.00
YoY Change -100.0%
Cash From Investing Activities $87.50K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.05K 90.33K
YoY Change -85.55% 56.52%
NET CHANGE
Cash From Operating Activities -227.0K -70.80K
Cash From Investing Activities 87.50K 0.000
Cash From Financing Activities 13.05K 90.33K
Net Change In Cash -126.4K 19.53K
YoY Change -747.47% -29.34%
FREE CASH FLOW
Cash From Operating Activities -$227.0K -$70.80K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001558740
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85159075 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18326075 shares
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
117183 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
285159075 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56204
dei Entity Registrant Name
EntityRegistrantName
WINVEST GROUP LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2052033
dei Entity Address Address Line1
EntityAddressAddressLine1
50 West Liberty Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 880
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89501
dei City Area Code
CityAreaCode
775
dei Local Phone Number
LocalPhoneNumber
996-0288
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
285159075 shares
CY2024Q2 us-gaap Cash
Cash
38129 usd
CY2023Q4 us-gaap Cash
Cash
45070 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19200 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4100 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3477 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15710 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
117183 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61230 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
177989 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
126110 usd
CY2024Q2 us-gaap Investments
Investments
9826 usd
CY2023Q4 us-gaap Investments
Investments
800 usd
CY2024Q2 us-gaap Security Deposit
SecurityDeposit
1094 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
1094 usd
CY2024Q2 us-gaap Assets
Assets
188909 usd
CY2023Q4 us-gaap Assets
Assets
128004 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2328 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
76451 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
58935 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54317 usd
CY2024Q2 wnlv Project Advances Current
ProjectAdvancesCurrent
100000 usd
CY2023Q4 wnlv Project Advances Current
ProjectAdvancesCurrent
100000 usd
CY2024Q2 wnlv Project Advances Related Party
ProjectAdvancesRelatedParty
150000 usd
CY2023Q4 wnlv Project Advances Related Party
ProjectAdvancesRelatedParty
150000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
18670 usd
CY2024Q2 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
633933 usd
CY2023Q4 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
631157 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
945196 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1030595 usd
CY2024Q2 us-gaap Liabilities
Liabilities
945196 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1030595 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
226688680 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
226689 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85159075 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18326075 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
85159 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18326 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103714814 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103571797 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104782949 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104720553 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-756287 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-902591 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
188909 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128004 usd
CY2024Q2 us-gaap Revenues
Revenues
12500 usd
CY2023Q2 us-gaap Revenues
Revenues
54769 usd
us-gaap Revenues
Revenues
77340 usd
us-gaap Revenues
Revenues
164978 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
5840 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
39828 usd
us-gaap Cost Of Revenue
CostOfRevenue
42760 usd
us-gaap Cost Of Revenue
CostOfRevenue
108307 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
6660 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
14941 usd
us-gaap Gross Profit
GrossProfit
34580 usd
us-gaap Gross Profit
GrossProfit
56671 usd
CY2024Q2 wnlv Administrative Expense
AdministrativeExpense
148014 usd
CY2023Q2 wnlv Administrative Expense
AdministrativeExpense
139428 usd
wnlv Administrative Expense
AdministrativeExpense
245757 usd
wnlv Administrative Expense
AdministrativeExpense
835949 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
148014 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
139428 usd
us-gaap Operating Expenses
OperatingExpenses
245757 usd
us-gaap Operating Expenses
OperatingExpenses
835949 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-141354 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-124487 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-211177 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-779278 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
833 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
6099 usd
us-gaap Interest Expense
InterestExpense
2044 usd
us-gaap Interest Expense
InterestExpense
6099 usd
CY2024Q2 us-gaap Other Income
OtherIncome
1044 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
1853 usd
us-gaap Other Income
OtherIncome
0 usd
CY2024Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
87403 usd
CY2023Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
14313 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
148972 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
14313 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
87614 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8214 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
148781 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8214 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53740 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116273 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62396 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-771064 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-53740 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-116273 usd
us-gaap Net Income Loss
NetIncomeLoss
-62396 usd
us-gaap Net Income Loss
NetIncomeLoss
-771064 usd
CY2024Q2 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2023Q2 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.01
wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04
CY2024Q2 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
488492408 shares
CY2023Q2 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
17526075 shares
wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
381479379 shares
wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
17501327 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
458040 usd
CY2023Q1 wnlv Misc Common Stock Adjustment Amount
MiscCommonStockAdjustmentAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654791 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-682719 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-116273 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-798991 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-902591 usd
CY2024Q1 wnlv Issuance Of Shares For Investment Amount
IssuanceOfSharesForInvestmentAmount
9200 usd
CY2024Q1 wnlv Conversion Of Preferred Stock To Common Stock Amount
ConversionOfPreferredStockToCommonStockAmount
0 usd
CY2024Q1 wnlv Private Placement Of Common Shares Amount
PrivatePlacementOfCommonSharesAmount
199500 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8656 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-702547 usd
CY2024Q2 wnlv Cancellation Of Common Shares In Return Of Preferred Stock Amount
CancellationOfCommonSharesInReturnOfPreferredStockAmount
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-53740 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-756287 usd
us-gaap Profit Loss
ProfitLoss
62396 usd
us-gaap Profit Loss
ProfitLoss
771064 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
458040 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
148972 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15100 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12727 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-12233 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
14310 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
55953 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-148054 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1094 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74123 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
40649 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4618 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5336 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-339693 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132334 usd
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
149146 usd
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
149146 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
64118 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
18670 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
199500 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
113736 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11776 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
257999 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
183606 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
208381 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6941 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
76047 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45070 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37148 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38129 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113195 usd
wnlv Purchase Of Investment With Common Shares
PurchaseOfInvestmentWithCommonShares
9200 usd
wnlv Purchase Of Investment With Common Shares
PurchaseOfInvestmentWithCommonShares
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities at the date of the condensed consolidated financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The cost of revenue is comprised of labor expenses calculated based on an hourly labor rate provided by consultants and employees to produce revenue, as well as portion of office expense which is allocated to each project. Additionally, the cost of revenue includes direct expenses related to the revenues provided, such as managing the client’s Amazon sales channel through the creation of promotional advertisements to increase sales, translation of content into different languages, coordination of projects with different work teams to maximize client benefits, production crew for celebrity endorsements and video shooting, and salaries and wages of employees involved in creating and delivering these services.</p>
CY2023Q4 wnlv Advances From Related Parties
AdvancesFromRelatedParties
631157 usd
CY2022Q4 wnlv Advances From Related Parties
AdvancesFromRelatedParties
601649 usd
CY2024Q2 wnlv Advances From Related Parties
AdvancesFromRelatedParties
633933 usd
CY2023Q4 wnlv Advances From Related Parties
AdvancesFromRelatedParties
631157 usd
wnlv Income Tax Expense Benefits
IncomeTaxExpenseBenefits
-13103 usd
wnlv Income Tax Expense Benefits
IncomeTaxExpenseBenefits
-161923 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
61230 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18326075 shares
CY2024Q1 wnlv Number Of Common Stock Cancelled
NumberOfCommonStockCancelled
550000000 shares
CY2024Q1 wnlv Number Of Preferred Stock Cancelled
NumberOfPreferredStockCancelled
11000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
855000 shares
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3420 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
226688680 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares

Files In Submission

Name View Source Status
0001477932-24-005146-index-headers.html Edgar Link pending
0001477932-24-005146-index.html Edgar Link pending
0001477932-24-005146.txt Edgar Link pending
0001477932-24-005146-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wnlv-20240630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wnlv-20240630_def.xml Edgar Link unprocessable
wnlv_10q.htm Edgar Link pending
wnlv_ex311.htm Edgar Link pending
wnlv_ex312.htm Edgar Link pending
wnlv_ex321.htm Edgar Link pending
wnlv_ex322.htm Edgar Link pending
wnlv-20240630_lab.xml Edgar Link unprocessable
wnlv-20240630_pre.xml Edgar Link unprocessable
wnlv_10q_htm.xml Edgar Link completed
wnlv-20240630_cal.xml Edgar Link unprocessable